Amedisys, UnitedHealth

Justice Department Sues to Block UnitedHealth’s $3.3 Billion Bid for Amedisys
Antitrust enforcers argue that the healthcare giant’s latest deal would illegally harm competition.
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys
Minnesota-based UnitedHealth Group Inc. is the focus of an antitrust lawsuit filed on Tuesday by the United States Department of Justice.
Amedisys falls as DOJ sues to block $3.3B sale to UnitedHealth (update)
Amedisys (NASDAQ:AMED) dropped 1.5% as the Dept. of Justice confirmed a lawsuit to challenge the home-health services provider's planned $3.3 billion sale to UnitedHealth (UNH). The DOJ and three states filed a lawsuit on Tuesday to block the combination,
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market for home health services,
U.S. Regulators Seek to Block UnitedHealth’s $3.3 Billion Purchase of Home Care Company
The Justice Department and four Democratic state attorneys general argued that United’s takeover would limit competition and harm consumers needing home or hospice care.
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys
The government is citing concerns the deal would hinder access to home health and hospice services in the U.S.
Justice Department sues to block UnitedHealth’s $3.3 billion deal to acquire Amedisys
The complaint marks the second time since 2022 that DOJ has challenged deals in the Minnetonka-based company’s Optum division for health care services.
Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc.
The Justice Department and four Attorneys General have blocked UnitedHealth Group Incorporated’s $3.3 billion acquisition of Amedisys Inc. The Attorneys General of Maryland, Illinois, New Jersey, and New York joined the blockade alongside the legal watchdog of the United States government,
UnitedHealth-Amedisys merger targeted by Justice Department
UnitedHealth Group's $3.3 billion acquisition of Amedisys, the largest M&A deal for a Minnesota company in 2023, is being targeted by antitrust regulators who say the merger would hurt competition in the home health care sector.
Justice Department sues to block United Health merger with Amedisys
The U.S. Department of Justice, along with the attorneys general from Maryland, Illinois, New Jersey, and New York, has filed a civil antitrust lawsuit to
'Health Care Behemoth'?: DOJ Seeks Injunction Blocking $3.3B UnitedHealth Merger Proposal
The Justice Department will not hesitate to check unlawful consolidation and monopolization in the health care market that ...
Yahoo2d
DOJ sues UnitedHealth Group in attempt to block $3.3B acquisition
The U.S. Department of Justice and four state attorney generals filed an antitrust lawsuit against UnitedHealth Group on ...
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to ...
Modern Healthcare2d
Why UnitedHealth, Amedisys are standing behind their deal
UnitedHealth Group's Optum said the Justice Department's lawsuit to stop its acquisition of Amedisys is an overreach.
DOJ Lawsuit Threatens to Derail UnitedHealth’s Effort to Buy Another Home Health Provider
A new Department of Justice lawsuit has put at risk UnitedHealth Group effort to buy Amedisys one of the country’s largest ...
UnitedHealth (UNH) Up 6% Since Last Earnings Report: Can It Continue?
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dow's 238-point fall led by losses in UnitedHealth, Salesforce shares
Shares of UnitedHealth and Salesforce are posting losses Thursday afternoon, dragging the Dow Jones Industrial Average into negative territory. ‘How can I convince her?’ We’re in our late 60s with ...